$LQDA

Bloch Stephen M sold $17.8M of LQDA (indirect holdings)

Bloch Stephen M sold 200,000 indirectly-held shares of Liquidia Corp (LQDA) at an average of $88.93 ($87.70–$90.71, $17.79M total) across 5 trades over 2026-07-22 to 2026-07-23.

Original reporting
SEC EDGAR · Bloch Stephen M
Published Jul 24, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

The only new information is the size and timing of the director’s open-market sale (200,000 shares, $17.79M total).

02

Market read

Traders may monitor for follow-on insider activity or correlate with price/volume, but there is no direct fundamental trigger in the text.

03

What to watch

The filing notes no 10b5-1 plan, but it also provides no rationale for the sale; without additional context, traders should avoid assuming negative company outlook.

Relevance 7/10Novelty 3/10Timing: Filed on 2026-07-24 after trades on 2026-07-22 to 2026-07-23.

Background

The article is an SEC Form 4 insider transaction disclosure for Liquidia Corp director Stephen M. Bloch.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia director Stephen M. Bloch sold about 200,000 shares in open-market trades totaling $17.79M, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should be weighed against broader tape and fundamentals.

Evidence & confidence

This is a routine Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

No clear sector read-through because the disclosure is limited to an individual director’s sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • Liquidia Corp

    Subject of the Form 4 insider transaction disclosure (LQDA).

  • Stephen M. Bloch

    Director who sold shares via open-market transactions; holdings reduced to 501,477 shares after the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LQDAHighAI 8/10

Why is Liquidia stock cratering today?

Liquidia Corporation's stock fell 48.3% to $36.55 after a court ruled it infringed two claims of United Therapeutics' patent, impacting its YUTREPIA drug. The company plans to remove a key indication and may face further restrictions. United Therapeutics' stock rose. The broader market gained slightly.